Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression G/GEJC

NCT07273981 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric/Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Zanidatamab Combined with Chemotherapy

Sponsor

Xijing Hospital